INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Narrative review / 2015

A review discusses diet, gut microbiota-derived TMAO, and cardiovascular concerns in nondialysis chronic kidney disease patients.

This narrative review examines dietary factors, gut microbiota, and the uremic toxin trimethylamine N-oxide (TMAO) in patients with nondialysis chronic kidney disease (CKD). Low-protein diets are recommended in this population because excess protein can harm kidney function and generate uremic toxins. TMAO, a degradation product of choline and L-carnitine derived primarily from animal protein such as red meat and eggs, is considered a proatherogenic metabolite with potential cardiovascular implications in CKD.

Study type
Narrative review
Who was studied
Nondialysis chronic kidney disease patients
What was measured
Relationship between TMAO, diet, and cardiovascular aspects in CKD patients

THE PAPER

Trimethylamine N-Oxide From Gut Microbiota in Chronic Kidney Disease Patients: Focus on Diet.

Moraes C, Fouque D, Amaral AC, Mafra D. J Ren Nutr, 2015.

PubMed 26235933 ↗DOI 10.1053/j.jrn.2015.06.004 ↗

Heart & arteriesGut & microbiomeNutrients & adequacyKidney health

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.